Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
295M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
48.7M
-
Shares change
-
-353K
-
Total reported value, excl. options
-
$292M
-
Value change
-
-$3.98M
-
Put/Call ratio
-
0.4
-
Number of buys
-
71
-
Number of sells
-
-53
-
Price
-
$6.05
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2016
170 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q1 2016.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.7M shares
of 295M outstanding shares and own 16.52% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (6.95M shares), BAKER BROS. ADVISORS LP (4.06M shares), Bank of New York Mellon Corp (3.36M shares), FMR LLC (3.03M shares), BlackRock Fund Advisors (2.57M shares), VANGUARD GROUP INC (2.46M shares), STATE STREET CORP (2.25M shares), RA CAPITAL MANAGEMENT, LLC (2.21M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.85M shares), and BlackRock Institutional Trust Company, N.A. (1.77M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.